Company / Return on Assets (ROA)
Cartesian Therapeutics, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-26.1%
FY2025
5-year range
-50.5% / -8.4%
FY2021-FY2025
Trend
+48.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 8 years, ranging from -65.6% in FY2019 to -8.4% in FY2023.
Based on SEC 10-K filings.
-26.1% in FY2025 with a 5-year CAGR of +13.4%.
Declined from -8.4% to -26.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +15.4pp
- 5-Year Change
- +13.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 48.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2023.
- Lowest return on assets (roa) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -26.1% | +48.3% |
| FY2024 | -50.5% | -499.9% |
| FY2023 | -8.4% | +79.7% |
| FY2022 | -41.5% | -19.9% |
| FY2021 | -34.6% | +12.3% |
| FY2020 | -39.5% | +39.8% |
| FY2019 | -65.6% | -354.9% |
| FY2016 | -14.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026